沙门氏菌诱导的癌症免疫治疗中的细胞死亡:背后有什么?
Amy Mónaco1, Sofía Chilibroste1, María Clara Plata1
1Unidad Académica de Desarrollo Biotecnológico, Instituto de Higiene, Facultad de Medicina, Universidad de la República, Montevideo 11600, Uruguay.
Biomedicines
|January 28, 2026
概括
沙门氏菌细菌通过诱导细胞死亡和刺激免疫反应,显示出癌症免疫治疗的前景. 本综述阐明了由沙门氏菌引起的不同类型的细胞死亡,如亡和热亡,以改善癌症治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 基于细菌的癌症免疫疗法正在获得吸引力,因为人们对其机制的理解得到了改善.
- 沙门氏菌是一种经过充分研究的细菌,由于其诱导瘤细胞死亡和免疫刺激的能力,在癌症治疗中具有潜力.
- 在炎症环境下瘤细胞死亡可以增强抗原释放和抗瘤免疫反应.
研究的目的:
- 综合审查沙门氏菌诱导的细胞死亡模式,包括亡,热亡和自.
- 在当前的定义和概念中组织有关沙门氏菌诱导的细胞死亡的现有数据.
- 通过操纵这些途径来优化基于细菌的免疫疗法的挑战.
主要方法:
- 对沙门氏菌诱导的细胞死亡现有文献进行系统审查.
- 专注于骨髓状细胞的证据,整合来自瘤和其他免疫细胞的数据.
- 根据当前的命名和分类,分析细胞死亡机制.
主要成果:
- 沙门氏菌诱导各种细胞死亡模式,包括亡,热亡和自,重点关注髓状细胞.
- 不一致的命名法和重叠的标准使得沙门氏菌诱导的细胞死亡的分类变得复杂.
- 了解这些途径对于开发有效的基于细菌的癌症免疫疗法至关重要.
结论:
- 澄清沙门氏菌诱导的细胞死亡机制对于推进基于细菌的癌症免疫疗法至关重要.
- 需要进一步的研究,以克服操纵这些途径以获得治疗益处的挑战.
- 细胞死亡模式的标准化分类将有助于开发基于沙门氏菌的优化癌症治疗方法.
相关概念视频
Autophagic Cell Death
4.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.5K
Overview of Cell Death
9.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.8K
Tumor Immunotherapy
1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Mechanisms of Retrovirus-induced Cancers
7.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
Induced Pluripotent Stem Cells
28.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K
Induced Pluripotent Stem Cells
5.6K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.6K


